Table 1.
The distribution of subjects’ baseline data and characters.
| Variable | Classification | Subject | Death | Death% | Person-year | All-cause Mortality rate (per 1000) |
|---|---|---|---|---|---|---|
| Initial vascular Access type | AVF/AVG | 599 | 202 | 33.7% | 2879.36 | 70.15 (60.48,79.82) |
| Catheter | 139 | 41 | 29.5% | 402.34 | 101.90 (70.71,133.09) | |
| Vascular Access type | AVF/AVG only | 436 | 130 | 29.8% | 2182.43 | 59.6 (49.3,69.8) |
| AVF/AVG plus catheter | 270 | 98 | 36.3% | 1016.66 | 96.4 (77.3, 115.5) | |
| Catheter only | 32 | 15 | 46.9% | 82.61 | 181.6 (89.7, 273.5.8) | |
| Age group | 40–49 | 111 | 12 | 10.8% | 610.81 | 19.7 (8.5, 30.8) |
| 50–59 | 260 | 67 | 25.8% | 1203.79 | 55.7 (42.3, 69.0) | |
| 60–69 | 191 | 70 | 36.7% | 862.95 | 81.1 (62.1, 100.1) | |
| 70–79 | 176 | 94 | 53.4% | 604.13 | 155.6 (124.1, 187.0) | |
| Gender | Female | 368 | 124 | 33.7% | 1652.4 | 75.0 (61.8, 88.3) |
| Male | 370 | 119 | 32.2% | 1629.3 | 73.0 (59.9, 86.2) | |
| Fasting Plasma Glucose(mg/dl) | <126 | 415 | 109 | 26.3% | 1962.4 | 55.5 (45.1, 66.0) |
| 126 | 323 | 134 | 41.5% | 1319.3 | 101.6 (84.4, 118.8) | |
| Albumin (g/dl) | 3.5 | 537 | 161 | 30.0% | 2516.7 | 64.0 (54.1, 73.9) |
| <3.5 | 201 | 82 | 40.8% | 765.0 | 107.2 (84.0, 130.4) | |
| hsCRP (mg/L) | <4 | 426 | 116 | 27.2% | 2062.7 | 56.2 (46.0, 66.5) |
| 4 | 281 | 110 | 39.2% | 1132.9 | 97.1 (79.0, 115.2) | |
| NK | 31 | 17 | 86.0 | 197.6 (103.7, 291.5) | ||
| Cholesterol (mg/dl) | <240 | 703 | 228 | 32.4% | 3108.2 | 73.4 (63.8, 82.9) |
| 240 | 35 | 15 | 42.9% | 173.5 | 86.5 (42.7, 130.2) | |
| Triglyceride (mg/dl) | <200 | 544 | 158 | 29.0% | 2384.2 | 66.3 (55.9, 76.6) |
| 200 | 194 | 85 | 43.8% | 897.5 | 94.7 (74.6, 114.8) | |
| Uric acid (mg/dl) | <8 | 510 | 155 | 30.4% | 2194.2 | 70.6 (59.5, 81.8) |
| 8 | 226 | 87 | 38.5% | 1082.1 | 80.4 (63.5, 97.3) | |
| NK | 2 | 1 | ||||
| AST (IU/L) | <40 | 698 | 222 | 31.8% | 3150.4 | 70.5 (61.2, 79.7) |
| 40 | 40 | 21 | 52.5% | 131.3 | 159.9 (91.5, 228.3) | |
| ALT (IU/L) | <40 | 693 | 224 | 32.3% | 3105.1 | 72.1 (62.7, 81.6) |
| 40 | 45 | 19 | 42.2% | 176.6 | 107.6 (59.2, 156.0) | |
| URR (%) | 65% | 607 | 197 | 32.5% | 2723.1 | 72.4 (62.3, 82.5) |
| <65% | 126 | 43 | 34.1% | 535.00 | 80.4 (56.4, 104.4) | |
| NK | 5 | 3 | ||||
| Hb (g/dL) | 8.5 | 566 | 186 | 32.9% | 2418.1 | 76.9 (65.9, 88.0) |
| <8.5 | 172 | 57 | 33.1% | 863.7 | 66.0 (48.9, 83.1) | |
| Hct (%) | 28 | 437 | 144 | 33.0% | 1801.3 | 79.9 (66.9, 93.0) |
| <28 | 301 | 99 | 32.9% | 1480.4 | 66.9 (53.7,80.0) |
AVF: arteriovenous fistula; AVG: arteriovenous graft; URR: Urea reduction ratio; AST: aspartate aminotransferase; ALT: alanine aminotransferase; hs-CRP: high-sensitivity C-reaction protein; Hb: hemoglobin; Hct: hematocrit.
NK: not known.